Funding Opportunities

For questions regarding these opportunities, please contact Sarah Laye at: slaye@som.umaryland.edu.
Date Posted Organization Title Website Type LOI or Pre-Application Due Date Application Due Date Expiration Date Comments / Documents
Rising Tide Foundation for Clinical Cancer Research Rising Tide Foundation for Clinical Cancer Research Grant Foundation 06/22/26
Cancer Research Institute (CRI) Cancer Research Institute Career Development Awards (various) Foundation Various awards - visit website for deadlines
Blood Cancer United Blood Cancer United Equity in Access Research Grants Foundation 09/10/2026
Bladder Cancer Advocacy Network 2026 Bladder Cancer Advocacy Network (BCAN) Continuity Grant Foundation 06/29/26
NIH NIH Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) NIH Standard due dates apply 01/08/28
NCI NIH Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) NCI Standard due dates apply 01/08/27
NCI NIH Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) NIH Standard due dates apply 01/08/28
NCI NIH National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) NIH Standard due dates apply 01/08/27
NIH NIH Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) NIH Standard due dates apply 11/06/26
NIH NIH Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional) NIH Standard due dates apply 01/08/28
NCI NIH Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) NCI Standard due dates apply 01/08/28
NCI NIH Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) NCI Standard due dates apply 01/08/27
NCI NIH Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) NCI Standard due dates apply 01/08/28
NCI NIH Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) NCI Standard due dates apply 01/08/28
NIH NIH Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) NIH Standard due dates apply 05/08/27
NCI NIH Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) NCI Standard due dates apply 01/08/27
NCI NIH Metastasis Research Network (U54 Clinical Trial Not Allowed) NCI 09/25/26
NCI NCI Cancer Prevention Fellowship Program (CPFP) NCI 08/06/26
NCI NIH Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) NCI 11/10/26
NCI NIH Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) NCI 11/10/26
NIH NIH Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) NIH 01/25/27
NCI NIH Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) NCI 09/11/27
NIH NIH Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) NIH Standard due dates apply 11/06/26
NIH NIH Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) NIH 10/19/26
NIH NIH Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) NIH 10/19/26
NIH NIH Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) NIH 10/19/27
NCI NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed) NCI 09/18/26
NCI NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required) NCI 09/18/26
Pfizer Pfizer Guideline Concordant Care and Emerging Data for Patients with Muscle Invasive Bladder Cancer (MIBC) through locally advanced or metastatic Urothelial Carcinoma (la/mUC) Industry 07/02/26
Edward Mallinckrodt, Jr. Foundation Edward Mallinckrodt, Jr. Foundation Grant Program Foundation 07/01/26
Hopper-Belmont Foundation The Hopper-Belmont Foundation (“HBF”) 2026 Awards Foundation 06/30/26
American Association for Cancer Research AACR Fellows of the AACR Academy Cancer Research Impact Grants Foundation 06/30/26
American Association for Cancer Research (AACR) AACR Gertrude B. Elion Cancer Research Award Industry 06/04/2026 09/16/26
NCI NIH Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed) NCI 03/12/29
NCI NIH Metastasis Research Network (U54 Clinical Trial Not Allowed) NCI Standard due dates apply 09/26/26
NIH NIH Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional) NIH Standard due dates apply 01/08/28
NIH NIH Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) NIH Standard due dates apply 01/08/27
NIH NIH Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) NIH Standard due dates apply 01/08/28
NIH NIH Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) NIH Standard due dates apply 01/08/27
NCI NIH Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Standard due dates apply 01/08/28
NCI NIH Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) NCI Standard due dates apply 01/08/28
NCI NIH Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) NCI Standard due dates apply 01/08/28
UMSOM Center for Advanced Research Training & Innovation (CARTI) CARTI Grant Review Service Internal 06/30/2026 08/21/26
Lung Cancer Research Foundation (LCRF) 2026 LCRF Award on Advancing Breakthroughs in ALK-Positive Lung Cancer Foundation 07/15/2026 09/29/26 LOI submission deadline is midnight on July 15, 2026. The full proposal submission deadline is September 29, 2026.
Lung Cancer Research Foundation (LCRF) and AstraZeneca 2026 LCRF | AstraZeneca Research Award on Strategies Using Patient Advocacy to Improve Outcomes in Small Cell Lung Cancer Foundation 07/15/2026 10/05/26 LOI submission deadline is July 15, 2026. The full proposal submission deadline is October 5, 2026.
Lung Cancer Research Foundation (LCRF) and AstraZeneca 2026 LCRF | AstraZeneca Research Award on Strategies Towards Improving the Treatment of Small Cell Lung Cancer Foundation 07/15/2026 10/05/26 LOI submission deadline is July 15, 2026. The full proposal submission deadline is October 5, 2026.
Department of War - Congressionally Directed Medical Research Programs (CDMRP) FY26 Peer Reviewed Medical Research Program (PRMRP) - various awards DOW Pre-application/LOI and application deadlines vary by award - visit website
Department of War - Congressionally Directed Medical Research Programs (CDMRP) FY26 Prostate Cancer Research Program (PCRP) - various awards DOW 08/12/2026 09/02/26
Department of War - Congressionally Directed Medical Research Programs (CDMRP) FY26 Lung Cancer Research Program (LCRP) - various awards DOW 09/02/26 Pre-application/LOI due dates vary by award - visit website
Department of War - Congressionally Directed Medical Research Programs (CDMRP) FY26 Breast Cancer Research Program (BCRP) - various awards DOW Pre-application/LOI and application deadlines vary by award - visit website